Troyen A. Brennan, EVP, Chief Medical Officer at CVS CAREMARK CORP (CVS), sold 139,618 shares at $57.34 ($8.0M) on 2013-04-15, disclosed to the SEC on 2013-04-16.
Scheduled sale ($8.0M) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.22 | 34,423 | $2.0M | 24.6% |
| 2 | $57.34 | 34,422 | $2.0M | 24.7% |
| 3 | $57.34 | 70,773 | $4.1M | 50.7% |
| Total | $57.31 avg | 139,618 | $8.0M | 100% |
| Filing → |
| CVS | SELL | 2021-10-28 | $7.3M | — | Filing → |
| CVS | SELL | 2021-09-07 | $228K | — | Filing → |
| CVS | SELL | 2021-06-17 | $5.8M | — | Filing → |